Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Sales, net	$ 7,522	$ 8,152	$ 25,501	$ 24,027
Cost of sales	6,795	6,915	21,708	20,086
Gross profit	727	1,237	3,793	3,941
Selling and administrative expenses	923	1,072	2,710	3,377
Operating (loss) income	(196)	165	1,083	564
Other income (expense), net
Change in fair value of derivative liabilities	10	(174)	19	(602)
Impairment charge on investment in iBio, Inc.		(139)		(139)
Other income (expense), net		(131)	5	244
Interest expense	(237)	(248)	(731)	(736)
Other expense, net	(227)	(692)	(707)	(1,233)
(Loss) income before income taxes	(423)	(527)	376	(669)
Income tax expense, net	27	5	131	18
Net (loss) income	$ (450)	$ (532)	$ 245	$ (687)
Basic net (loss) income per common share (in Dollars per share)	$ (0.02)	$ (0.03)	$ 0.01	$ (0.03)
Diluted net (loss) income per common share (in Dollars per share)	$ (0.02)	$ (0.03)	$ 0.01	$ (0.03)
Weighted average common shares outstanding - basic (in Shares)	21,080,174	21,080,174	21,080,174	21,080,174
Add: Stock options (in Shares)			79,745
Weighted average common shares outstanding - diluted (in Shares)	21,080,174	21,080,174	21,159,919	21,080,174